1,146
Views
0
CrossRef citations to date
0
Altmetric
Anemia and Hematologic Disorders

Light-chain proximal tubulopathy: a retrospective study from a single Chinese nephrology referral center

, , , &
Article: 2283587 | Received 28 Aug 2023, Accepted 09 Nov 2023, Published online: 19 Feb 2024

References

  • Maldonado JE, Velosa JA, Kyle RA, et al. Fanconi syndrome in adults. Am J Med. 1975;58(3):1–7. doi: 10.1016/0002-9343(75)90601-4.
  • Stokes MB, Valeri AM, Herlitz L, et al. Light chain proximal tubulopathy: clinical and pathologic characteristics in the modern treatment era. J Am Soc Nephrol. 2016;27(5):1555–1565. doi: 10.1681/ASN.2015020185.
  • Leung N, Bridoux F, Batuman V, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the international kidney and monoclonal gammopathy research group. Nat Rev Nephrol. 2019;15(1):45–59. doi: 10.1038/s41581-018-0077-4.
  • Sirac C, Batuman V, Sanders PW. The proximal tubule toxicity of immunoglobulin light chains. Kidney Int Rep. 2021;6(5):1225–1231. doi: 10.1016/j.ekir.2021.02.026.
  • Herrera GA. Proximal tubulopathies associated with monoclonal light chains: the spectrum of clinicopathologic manifestations and molecular pathogenesis. Arch Pathol Lab Med. 2014;138(10):1365–1380. doi: 10.5858/arpa.2013-0493-OA.
  • Fogo AB, Lusco MA, Najafian B, et al. AJKD atlas of renal pathology: light chain proximal tubulopathy. Am J Kidney Dis. 2016;67(2):e9–e10. doi: 10.1053/j.ajkd.2015.12.006.
  • Fermand JP, Bridoux F, Kyle RA, et al. How I treat monoclonal gammopathy of renal significance (MGRS). Blood. 2013;122(22):3583–3590. doi: 10.1182/blood-2013-05-495929.
  • WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Published 2021. Accessed December 3, 2022. https://www.who.int/data/nutrition/nlis/info/anaemia.
  • Unger T, Borghi C, Charchar F, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–1357. doi: 10.1161/HYPERTENSIONAHA.120.15026.
  • Larsen CP, Bell JM, Harris AA, et al. The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation. Mod Pathol. 2011;24(11):1462–1469. doi: 10.1038/modpathol.2011.104.
  • Bridoux F, Sirac C, Hugue V, et al. Fanconi’s syndrome induced by a monoclonal Vκ3 light chain in Waldenström’s macroglobulinemia. Am J Kidney Dis. 2005;45(4):749–757. doi: 10.1053/j.ajkd.2004.12.020.
  • Rocca A, Khamlichi AA, Touchard G, et al. Sequences of V kappa L subgroup light chains in Fanconi’s syndrome. Light chain V region gene usage restriction and peculiarities in myeloma-associated fanconi’s syndrome. J Immunol Baltim Md 1950. 1995;155(6):3245–3252. doi: 10.4049/jimmunol.155.6.3245.
  • Decourt C, Rocca A, Bridoux F, et al. Mutational analysis in murine models for myeloma-associated Fanconi’s syndrome or cast myeloma nephropathy. Blood. 1999;94(10):3559–3566. doi: 10.1182/blood.V94.10.3559.422k10_3559_3566.
  • Kousios A, Blakey S, Moran L, et al. Non-crystalline light chain proximal tubulopathy, a morphologically protean entity. Nephrol Dial Transplant. 2023;38(11):2576–2588. Published online April 29, doi: 10.1093/ndt/gfad085.
  • Avner ED, Harmon WE, Niaudet P, et al. Pediatric nephrology. 7th ed. Berlin (Heidelberg): Springer; 2016.
  • Qin A, Bo Yu X, Juan Zheng X, et al. Lessons for the clinical nephrologist: a rare case with MGRS characterized by combined crystalline light chain proximal tubulopathy and crystal-storing histiocytosis responding to daratumumab. J Nephrol. 2023;36(4):1203–1207. Published online March 1, doi: 10.1007/s40620-023-01584-1.